Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery | |
Li, Ting1; Jiang, Hu-Lin2; Tong, Yun-Guang3,4; Lu, Jin-Jian1![]() | |
2018-04-27 | |
Source Publication | JOURNAL OF HEMATOLOGY & ONCOLOGY
![]() |
ISSN | 1756-8722 |
Volume | 11 |
Abstract | Heat shock protein 90 (Hsp90) is a critical molecular chaperone protein that regulates the folding, maturation, and stability of a wide variety of proteins. In recent years, the development of Hsp90-directed inhibitors has grown rapidly, and many of these inhibitors have entered clinical trials. In parallel, the functional dissection of the Hsp90 chaperone machinery has highlighted the activity disruption of Hsp90 co-chaperone as a potential target. With the roles of Hsp90 co-chaperones being elucidated, cell division cycle 37 (Cdc37), a ubiquitous co-chaperone of Hsp90 that directs the selective client proteins into the Hsp90 chaperone cycle, shows great promise. Moreover, the Hsp90-Cdc37-client interaction contributes to the regulation of cellular response and cellular growth and is more essential to tumor tissues than normal tissues. Herein, we discuss the current understanding of the clients of Hsp90-Cdc37, the interaction of Hsp90-Cdc37-client protein, and the therapeutic possibilities of targeting Hsp90-Cdc37-client protein interaction as a strategy to inhibit Hsp90 chaperone machinery to present new insights on alternative ways of inhibiting Hsp90 chaperone machinery. |
Keyword | Hsp90 Chaperone Machinery Cdc37 Kinase Client Protein Interaction |
DOI | 10.1186/s13045-018-0602-8 |
URL | View the original |
Indexed By | SCI |
Language | 英语 |
WOS Research Area | Oncology ; Hematology |
WOS Subject | Oncology ; Hematology |
WOS ID | WOS:000431301500001 |
Publisher | BIOMED CENTRAL LTD |
The Source to Article | WOS |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | Institute of Chinese Medical Sciences |
Affiliation | 1.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau China 2.State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China 3.Department of Pathology, Xinxiang Medical University, 601 East Jinsui Ave, Xinxiang, Henan China 4.Omigen, Inc., 15375 Barranca Pkwy, Irvine, CA H106 USA |
First Author Affilication | Institute of Chinese Medical Sciences |
Recommended Citation GB/T 7714 | Li, Ting,Jiang, Hu-Lin,Tong, Yun-Guang,et al. Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY,2018,11. |
APA | Li, Ting,Jiang, Hu-Lin,Tong, Yun-Guang,&Lu, Jin-Jian.(2018).Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery.JOURNAL OF HEMATOLOGY & ONCOLOGY,11. |
MLA | Li, Ting,et al."Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery".JOURNAL OF HEMATOLOGY & ONCOLOGY 11(2018). |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment